Work history

• Apr, 2021 – Present Professor (Professor Emeritus, University of Toyama), Center for Supporting Pharmaceutical Education, Daiichi University, Graduate School of Pharmaceutical Sciences
• Mar, 2020 – Mar, 2021 Daiichi University, College of Pharmaceutical Sciences
• Sep, 2004 – Mar, 2019 Professor, Division of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama
• Oct, 1991 – Aug, 2004 Associate Professor, Division of Pharmacology, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University
• Jun, 1988 – Sep, 1991 Lecturer, Division of Pharmacology, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University
• Oct, 1978 – 1988 Assistant Professor, Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Science, The University of Tokyo
• Nov, 1977 – Sep, 1978 Assistant Researcher, Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Science, The University of Tokyo

Research funds

by the National Institute of Informatics (NII) in cooperation with MEXT and JSPS

1. Project Period (FY) 2 0 15 – 2 01 8 Investigation of pathogenic mechanisms and Kampo medicine-based preventive and therapeutic strategy for ADHD using an epigenetic animal model.
2. Project Period (FY) 2012 – 2015 Kampo medicine pharmacology-based clarification and identification of etiologic factors and their function responsible for ADHD
3. Project Period (FY) 2 0 0 8 – 2 0 1 0 Studies on endogenous neuronal mediator with responsibility for anti-dementia effect of Kampo medicine
4. Project Period (FY) 2 0 0 5 – 2 0 0 7 Identification of the intrinsic molecules which are involved in the generation of disease, and the analysis of the molecular mechanisms and functions, by using Wakan-yaku, Japanese traditional systematized medicine
5. Project Period (FY) 2005 – 2007 Search, identification, and functional analysis of target molecules for cerebrovascular dementia treatment using bioactivities of Kampo medicines